Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the
law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the
proposed merger of Ohr Pharmaceutical, Inc. (“Ohr”) (NasdaqCM: OHRP)
with NeuBase Therapeutics, Inc. (“NeuBase”) in a stock-for-stock
transaction. KSF is seeking to determine whether the merger and the
process that led to it are adequate, or whether the merger undervalues
If you believe that this transaction undervalues the Company and/or if
you would like to discuss your legal rights regarding the proposed sale,
you may, without obligation or cost to you, e-mail or call KSF Managing
Partner Lewis S. Kahn (email@example.com)
toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-ohrp/
to learn more.
To learn more about KSF, whose partners include the Former Louisiana
Attorney General, visit www.ksfcounsel.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190211005787/en/